Older children and adolescents surviving with vertically acquired HIV infection.

This article describes the characteristics of children infected vertically with HIV surviving 10 years or more who were enrolled in the prospective European Collaborative Study. 34 of 187 infected children were identified with a median age of 11.4 years (range 10.1-15.9 years). Factors examined included clinical status immunologic and virologic characteristics type of antiretroviral therapy and psychosocial characteristics. By 10 years of age 6 (18%) children had progressed to Class A as determined by the system of the US Centers for Disease Control and Prevention 17 (52%) to class B 7 (21%) to class C and 3 (9%) had remained asymptomatic. At 73% (904 of 1234) of scheduled clinic visits these children had no symptoms of HIV disease. Most children were in Centers for Disease Control immune categories 1 (18 56%) or 2 (11 34%) at their last visit. Three-quarters (24 patients) were on combination therapy with three of more drugs although 3 children had never received any antiretroviral therapy. 19 (56%) children were living with at least 1 parent and the mothers of 13 (38%) children had died. Most (77%) children had been told about their HIV infection. Children infected vertically with HIV who have survived their first 10 years are mainly free of serious symptoms. As they enter adolescence additional services are needed including support with disclosure to others therapy and sexual health. (authors)

[1]  M. Newell,et al.  Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life. , 2001, Pediatrics.

[2]  P. Tovo Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial , 2001 .

[3]  D. Gibb Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial , 2001 .

[4]  P. Pezzotti,et al.  Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. , 2000, JAMA.

[5]  L. Mascola,et al.  Human immunodeficiency virus‐infected adolescents: a descriptive study of older children in New York City, Los Angeles County, Massachusetts and Washington, DC , 2000, The Pediatric infectious disease journal.

[6]  M E Duffy,et al.  Compliance in adolescents with chronic diseases: a review. , 2000, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[7]  C. Giaquinto,et al.  Variable use of therapeutic interventions for children with human immunodeficiency virus type 1 infection in Europe , 2000, European Journal of Pediatrics.

[8]  M. Newell,et al.  Disclosure of diagnosis and planning for the future in HIV-affected families in Europe. , 2000, Child: care, health and development.

[9]  G. Luftman,et al.  Antiretroviral adherence issues among HIV-positive adolescents and young adults. , 1999, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[10]  M. Newell,et al.  Clinical and psychosocial service needs of children and families affected by human immunodeficiency virus in Europe , 1999 .

[11]  D. Levy,et al.  Surveillance for waterborne-disease outbreaks--United States, 1995-1996. , 1998, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[12]  G. Kaufman,et al.  SUCCESSFUL PREGNANCY IN AN ADOLESCENT WITH PERINATALLY ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS , 1998, Obstetrics and gynecology.

[13]  P. Rosenberg,et al.  Trends in HIV incidence among young adults in the United States. , 1998, JAMA.

[14]  C. Rouzioux,et al.  Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[15]  J. Oleske,et al.  Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. , 1995, Pediatrics.

[16]  H. Cohen,et al.  Developmental and service needs of school-age children with human immunodeficiency virus infection: a descriptive study. , 1994, Pediatrics.

[17]  Marie-Louise Newell,et al.  Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study. , 1994, Pediatrics.

[18]  P. Pizzo,et al.  PERSPECTIVES ON PEDIATRIC HUMAN IMMUNODEFICIENCY VIRUS INFECTION , 1993 .